Order of extension of CIRP period.

Regulatory & Legal View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

₹0.35

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+3.7%—

Telecom - Cellular & Fixed line services peers, median of 6sector+3.9%—

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—+1.0—+1.3—

Next day

—+3.7—+3.9—

—+0.8—+0.7—

—+1.7—+2.0—

-2.9-3.0+0.2-2.1-0.8

—-0.2—-1.3—

—-0.7—-5.1—

15d

-2.9+9.4-12.3+4.3-7.2

+8.6+14.8-6.3+4.9+3.6

+5.7+16.1-10.4+9.7-4.0

+2.9+26.4-23.6+18.9-16.0

UpDownMarket · Nifty Microcap 250Sector · Telecom - Cellular & Fixed line services peers, median of 6Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The NCLT Mumbai bench has extended the Corporate Insolvency Resolution Process (CIRP) for Quadrant Televentures Limited by 90 days, from March 2, 2026 to May 30, 2026. This is the first extension beyond the initial 180-day window permitted under the Insolvency and Bankruptcy Code, taking the total resolution timeline to 270 days. The extension was sought by Resolution Professional Rajesh Jhunjhunwala after Form-G was issued and 8 resolution plans were received from potential applicants. The company has been under CIRP since September 2, 2025, following a Section 7 petition filed by IDBI Trusteeship Services Limited.

Likely market impact

Shareholders should note that the insolvency resolution is taking longer than the original timeline, pushing the deadline to end-May 2026. While the receipt of 8 resolution plans indicates some bidding interest, the extended timeline keeps the stock under trading suspension and uncertainty around equity recovery remains high.